Search

Search Constraints

You searched for: Author/Creator Howell, Gareth R.

Search Results

2. Model organism development and evaluation for late‐onset Alzheimer's disease: MODEL‐AD. Issue 1 (23rd November 2020)

4. O1‐01‐03: GENETICALLY DIVERSE MOUSE MODELS OF ALZHEIMER'S DISEASE EXHIBIT DIFFERENTIAL MYELOID CELL RESPONSE AND NEURODEGENERATION. (1st July 2006)

5. O1‐06‐02: CONCUSSION, MICROVASCULAR INJURY, AND EARLY TAUOPATHY IN YOUNG ATHLETES AFTER IMPACT HEAD INJURY AND AN IMPACT CONCUSSION MOUSE MODEL. (1st July 2006)

6. O4‐01‐06: WHOLE‐EXOME ANALYSIS OF LATE‐ONSET ALZHEIMER'S DISEASE REVEALS NOVEL CANDIDATE GENES INVOLVED IN COGNITIVE FUNCTION. (1st July 2006)

7. P2‐045: THE MODEL‐AD CONSORTIUM PRECLINICAL TESTING PIPELINE: PHARMACOKINETICS AND PHARMACODYNAMICS OF PROPHYLACTIC TREATMENT WITH LEVETIRACETAM IN THE 5XFAD MOUSE MODEL OF ALZHEIMER'S DISEASE. (1st July 2006)

8. P4‐248: THE ROLE OF TREM2 EXPRESSION ON MYELOID CELLS IN ALZHEIMER'S DISEASE. (1st July 2014)

9. Perspectives on Cognitive Phenotypes and Models of Vascular Disease. Issue 7 (5th May 2022)

10. Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: A MODEL‐AD preclinical testing core study. Issue 1 (23rd August 2022)